Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada

Go back to Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
DR. REDDY'S LAB LTD ADR (NYSE: RDY) Delayed: 13.30 -0.06 (0.45%)
Previous Close $13.36    52 Week High $54.73 
Open $13.36    52 Week Low $40.68 
Day High $13.40    P/E N/A 
Day Low $13.30    EPS $0.00 
Volume 1,173,726